Gilead Sciences · 1 day ago
Intern - PDM - Drug Product Pilot Plant
Gilead Sciences is dedicated to creating a healthier world by tackling significant diseases and developing innovative therapies. As an intern, you will contribute to impactful projects while gaining real-world experience in solid oral dose manufacturing and 3D printing applications.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Work with plant operations team to understand solid oral dose manufacturing, current 3D printing applications and potentially identify new use cases
Use SolidWorks to create/modify 3D printed fixtures and components
Investigate material properties and technical specifications for various filaments, resins and post-processing agents
Assess potential risks and document in qualification roadmap
Showcase your work with a final presentation (PPT) near the conclusion of your internship
Qualification
Required
Must be at least 18 years old
Must have a minimum GPA of 2.8
Authorized to work in the United States without Sponsorship now or in the future
Must be currently enrolled as a full-time student in a Bachelor's/Master's at an accredited US based university or college
Must be a Rising Sophomore, Junior, or Senior in undergrad
Must be enrolled full-time in the Fall Semester at an accredited university/college after the completion of the internship
Must be able to complete a 10-12 consecutive week internship between May and August
Must be able to relocate and work at the designated site for the duration of the internship
Preferred
Preferred Degree qualification: Undergrad
Proficiency with SolidWorks and basic slicing programs
Understanding of how to set up, calibrate and maintain 3D printers (FDM, SLA, SLS)
Proficiency with MS Office Suite
Ability to identify issues and seek solutions
Ability to work both independently and collaboratively
Demonstrated commitment to inclusion and diversity in the workplace
Efficient, organized, and able to handle short timelines in a fast-paced environment
Benefits
Paid company holidays
Sick time
Housing stipends for eligible employees
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Recent News
2025-12-30
BioWorld Financial Watch
2025-12-29
Company data provided by crunchbase